Source disclosure: February 13, 2026
SUSMED,Inc. [4263.T]
TOKYO, Feb 23 (Pulse News Wire) – Susmed,Inc. (4263.T) reported consolidated results for Q2 FY2026 (ending June 2026).
9% YoY).
27 billion with an equity ratio of 95.6%.
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms •Financial results — FY2026/6 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥91M | +23.9% |
| Operating profit | ¥-286M | -283.0% |
| Net profit | n/a | n/a |
Source: TDNet filing · Figures in millions of yen
💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.